Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

News Daily News

The Smartphone Will See You Now: Clinical Research Can Be Done via App

Yael L. Maxwell

December 16, 2016

News Conference News AHA 2016

Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis

Michael O'Riordan

November 22, 2016

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

News Conference News AHA 2016

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Shelley Wood

November 13, 2016

News Features

Run, Walk, Bike: Doctors Open Up About Their Own Heart-Healthy Exercise Habits

Michael O'Riordan

November 11, 2016

News Daily News

Pfizer Discontinues Investigational PCSK9 Inhibitor Bococizumab

Michael O'Riordan

November 01, 2016

News Daily News

Study Explores Possible Mechanism to Explain Air Pollution-CVD Link

Todd Neale

October 27, 2016

News Daily News

Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa

Michael O'Riordan

September 16, 2016

News Industry News

Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers

September 15, 2016

News Daily News

Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns

Todd Neale

September 12, 2016

News Daily News

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Yael L. Maxwell

August 29, 2016

News Daily News

Weight Loss May Affect Diabetes Risk, but Not Future CVD Outlook

L.A. McKeown

August 04, 2016

News Daily News

Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use

Michael O'Riordan

June 28, 2016

News Daily News

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Michael O'Riordan

June 13, 2016

News Conference News EAS 2016

Good Fats, Bad Fats, and Sugar: A ‘Big Picture’ Approach Is Warranted With Diet Interventions for Cardiovascular Disease

Yael L. Maxwell

May 31, 2016

News Daily News

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

Caitlin E. Cox

March 23, 2016

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Todd Neale

November 10, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

Advertisement

The Smartphone Will See You Now: Clinical Research Can Be Done via App

Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Run, Walk, Bike: Doctors Open Up About Their Own Heart-Healthy Exercise Habits

Pfizer Discontinues Investigational PCSK9 Inhibitor Bococizumab

Study Explores Possible Mechanism to Explain Air Pollution-CVD Link

Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa

Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers

Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Weight Loss May Affect Diabetes Risk, but Not Future CVD Outlook

Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use

Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration

Good Fats, Bad Fats, and Sugar: A ‘Big Picture’ Approach Is Warranted With Diet Interventions for Cardiovascular Disease

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content